We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.88B
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
+32.38%
3 Year Est. Return
+99.93%
5 Year Est. Return
+115.9%
10 Year Est. Return
+395.31%
AUM
$1.13B
AUM Growth
+$103M
Cap. Flow
+$30.2M
Cap. Flow %
2.68%
Top 10 Hldgs %
16.52%
Holding
1,066
New
90
Increased
448
Reduced
352
Closed
73

Sector Composition

Rank Sector Weight
1 Miscellaneous 33.29%
2 Technology 13.45%
3 Healthcare 9.24%
4 Financials 8.88%
5 Consumer Discretionary 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CETX icon
926
Cemtrex
CETX
$4.35M
0
INSG icon
927
Inseego
INSG
$71.6M
$73K 0.01%
1,000
CLMT icon
928
Calumet Specialty Products
CLMT
$4.74B
$71K 0.01%
19,494
+2,000
+11% +$6.9K
MUX icon
929
McEwen Inc
MUX
$1.24B
$70K 0.01%
5,540
-7,500
-58% -$106K
NIO icon
930
NIO
NIO
$9.5B
$69K 0.01%
17,100
+5,200
+44% +$10.5K
TOVX icon
931
Theriva Biologics
TOVX
$11.3M
$67K 0.01%
526
+100
+23% +$10.6K
FAX
932
abrdn Asia-Pacific Income Fund
FAX
$599M
$66K 0.01%
2,572
-807
-24% -$20.6K
NSPR icon
933
InspireMD
NSPR
$38.9M
$65K 0.01%
4,042
+2,042
+102% +$32.3K
AUY
934
DELISTED
Yamana Gold, Inc.
AUY
$65K 0.01%
16,358
-3,126
-16% -$11K
SWN
935
DELISTED
Southwestern Energy Company
SWN
$62K 0.01%
25,600
-2,400
-9% -$4.96K
NSL
936
DELISTED
NUVEEN SENIOR INCM FD
NSL
$62K 0.01%
10,395
GALT icon
937
Galectin Therapeutics
GALT
$418M
$61K 0.01%
21,498
DVAX
938
DELISTED
Dynavax Technologies
DVAX
$60K 0.01%
10,500
AMPE
939
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$60K 0.01%
343
LQDA icon
940
Liquidia Corp
LQDA
$6.06B
$59K 0.01%
+13,900
New +$55.8K
NOG icon
941
Northern Oil and Gas
NOG
$2.74B
$59K 0.01%
2,504
-500
-17% -$9.9K
CPAH
942
DELISTED
Counterpath Corp
CPAH
$55K ﹤0.01%
58,716
+30,524
+108% +$33.1K
GASS icon
943
StealthGas
GASS
$345M
$53K ﹤0.01%
15,590
+2,740
+21% +$9.31K
QNRX
944
Quoin Pharmaceuticals
QNRX
$14.4M
$52K ﹤0.01%
1
-1
-50% -$51.3K
VLRX
945
DELISTED
VALERITAS HOLDINGS INC
VLRX
$52K ﹤0.01%
90,000
+73,609
+449% +$102K
TLGT
946
DELISTED
Teligent, Inc
TLGT
$48K ﹤0.01%
11,321
+9,260
+449% +$57.5K
ZVRA icon
947
Zevra Therapeutics
ZVRA
$753M
$47K ﹤0.01%
7,747
+1,658
+27% +$13.2K
UAN icon
948
CVR Partners
UAN
$1.4B
$45K ﹤0.01%
1,459
+446
+44% +$14.1K
OGI
949
Organigram Holdings
OGI
$161M
$44K ﹤0.01%
4,463
+850
+24% +$10K
VRDN icon
950
Viridian Therapeutics
VRDN
$2.62B
$42K ﹤0.01%
+5,880
New +$60.3K

Similar funds

Wedbush Securities's Q4 2019 Portfolio in Review

As of Q4 2019, Wedbush Securities held 1,066 positions worth $1.13B, up 10% from $1.02B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Wedbush Securities's Q4 2019 filing shows 90 new, 448 increased, 352 reduced and 73 closed positions. Its largest new stake was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 23,273 shares worth $2.36M. The largest sale was PAR Technology, an estimated $3.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 33% of assets, up from 32% a quarter earlier, followed by Technology and Healthcare.

  • Wedbush Securities's largest Q4 2019 buy was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 23,273 shares worth $2.36M.
  • Wedbush Securities added most to ExxonMobil in Q4 2019, an estimated $1.94M increase.
  • Wedbush Securities's biggest Q4 2019 reduction was PAR Technology, cutting an estimated $3.9M.
  • Wedbush Securities fully exited State Street SPDR Portfolio Short Term Corporate Bond ETF in Q4 2019, selling an estimated $1.59M.
  • Wedbush Securities's ten largest holdings make up 17% of its $1.13B portfolio in Q4 2019.
  • Wedbush Securities opened 90 new positions and closed 73 in Q4 2019.
  • Wedbush Securities's portfolio value rose 10% quarter-over-quarter to $1.13B.

Based on Wedbush Securities's 13F filing for Q4 2019, filed 16 Jan 2020.